BACKGROUND: In terms of time, effort and quality, multiplex technology is an attractive alternative for well-established single-biomarker measurements in clinical studies. However, limited data comparing these methods are available. METHODS: We measured, in a large ongoing cohort study (n = 574), by means of both a 4-plex multi-array biomarker assay developed by MesoScaleDiscovery (MSD) and single-biomarker techniques (ELISA or immunoturbidimetric assay), the following biomarkers of low-grade inflammation: C-reactive protein (CRP), serum amyloid A (SAA), soluble intercellular adhesion molecule 1 (sICAM-1) and soluble vascular cell adhesion molecule 1 (sVCAM-1). These measures were realigned by weighted Deming regression and compared across a wide spectrum of subjects' cardiovascular risk factors by ANOVA. RESULTS: Despite that both methods ranked individuals' levels of biomarkers very similarly (Pearson's r all≥0.755) absolute concentrations of all biomarkers differed significantly between methods. Equations retrieved by the Deming regression enabled proper realignment of the data to overcome these differences, such that intra-class correlation coefficients were then 0.996 (CRP), 0.711 (SAA), 0.895 (sICAM-1) and 0.858 (sVCAM-1). Additionally, individual biomarkers differed across categories of glucose metabolism, weight, metabolic syndrome and smoking status to a similar extent by either method. CONCLUSIONS: Multiple low-grade inflammatory biomarker data obtained by the 4-plex multi-array platform of MSD or by well-established single-biomarker methods are comparable after proper realignment of differences in absolute concentrations, and are equally associated with cardiovascular risk factors, regardless of such differences. Given its greater efficiency, the MSD platform is a potential tool for the quantification of multiple biomarkers of low-grade inflammation in large ongoing and future clinical studies.
BACKGROUND: In terms of time, effort and quality, multiplex technology is an attractive alternative for well-established single-biomarker measurements in clinical studies. However, limited data comparing these methods are available. METHODS: We measured, in a large ongoing cohort study (n = 574), by means of both a 4-plex multi-array biomarker assay developed by MesoScaleDiscovery (MSD) and single-biomarker techniques (ELISA or immunoturbidimetric assay), the following biomarkers of low-grade inflammation: C-reactive protein (CRP), serum amyloid A (SAA), soluble intercellular adhesion molecule 1 (sICAM-1) and soluble vascular cell adhesion molecule 1 (sVCAM-1). These measures were realigned by weighted Deming regression and compared across a wide spectrum of subjects' cardiovascular risk factors by ANOVA. RESULTS: Despite that both methods ranked individuals' levels of biomarkers very similarly (Pearson's r all≥0.755) absolute concentrations of all biomarkers differed significantly between methods. Equations retrieved by the Deming regression enabled proper realignment of the data to overcome these differences, such that intra-class correlation coefficients were then 0.996 (CRP), 0.711 (SAA), 0.895 (sICAM-1) and 0.858 (sVCAM-1). Additionally, individual biomarkers differed across categories of glucose metabolism, weight, metabolic syndrome and smoking status to a similar extent by either method. CONCLUSIONS: Multiple low-grade inflammatory biomarker data obtained by the 4-plex multi-array platform of MSD or by well-established single-biomarker methods are comparable after proper realignment of differences in absolute concentrations, and are equally associated with cardiovascular risk factors, regardless of such differences. Given its greater efficiency, the MSD platform is a potential tool for the quantification of multiple biomarkers of low-grade inflammation in large ongoing and future clinical studies.
Authors: A Becker; V W M van Hinsbergh; A Jager; P J Kostense; J M Dekker; G Nijpels; R J Heine; L M Bouter; C D A Stehouwer Journal: Eur J Clin Invest Date: 2002-01 Impact factor: 4.686
Authors: Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor Journal: Circulation Date: 2003-01-28 Impact factor: 29.690
Authors: Andrew S Levey; Josef Coresh; Tom Greene; Jane Marsh; Lesley A Stevens; John W Kusek; Frederick Van Lente Journal: Clin Chem Date: 2007-03-01 Impact factor: 8.327
Authors: Ioanna Tzoulaki; Gordon D Murray; Amanda J Lee; Ann Rumley; Gordon D O Lowe; F Gerald R Fowkes Journal: Circulation Date: 2007-04-02 Impact factor: 29.690
Authors: Robert C Kaplan; Aileen P McGinn; Alison E Baird; Susan L Hendrix; Charles Kooperberg; John Lynch; Daniel M Rosenbaum; Karen C Johnson; Howard D Strickler; Sylvia Wassertheil-Smoller Journal: J Stroke Cerebrovasc Dis Date: 2008 Nov-Dec Impact factor: 2.136
Authors: Rocio D Marchese; Derek Puchalski; Pamela Miller; Joseph Antonello; Olivia Hammond; Tina Green; Leonard J Rubinstein; Michael J Caulfield; Daniel Sikkema Journal: Clin Vaccine Immunol Date: 2009-01-21
Authors: Huaidong Du; Daphne L van der A; Marit M E van Bakel; Carla J H van der Kallen; Ellen E Blaak; Marleen M J van Greevenbroek; Eugène H J M Jansen; Giel Nijpels; Coen D A Stehouwer; Jacqueline M Dekker; Edith J M Feskens Journal: Am J Clin Nutr Date: 2008-03 Impact factor: 7.045
Authors: Tatjana Josefs; Kristiaan Wouters; Uwe J F Tietge; Wijtske Annema; Robin P F Dullaart; Tomas Vaisar; Ilja C W Arts; Carla J H van der Kallen; Coen D A Stehouwer; Casper G Schalkwijk; Ira J Goldberg; Edward A Fisher; Marleen M J van Greevenbroek Journal: J Clin Lipidol Date: 2019-10-31 Impact factor: 4.766
Authors: R T Ras; D Fuchs; W P Koppenol; C G Schalkwijk; A Otten-Hofman; U Garczarek; A Greyling; F Wagner; E A Trautwein Journal: J Nutr Sci Date: 2016-12-06
Authors: Suzan Wetzels; Mitchell Bijnen; Erwin Wijnands; José van de Gaar; Andika Tan; Susan Coort; Erik A L Biessen; Casper G Schalkwijk; Kristiaan Wouters Journal: Immunometabolism Date: 2020-04-17
Authors: William D Bennett; Sally Ivins; Neil E Alexis; Jihong Wu; Philip A Bromberg; Sukhdev S Brar; Gregory Travlos; Stephanie J London Journal: PLoS One Date: 2016-08-11 Impact factor: 3.240
Authors: Nynke Simons; Mitchell Bijnen; Kristiaan A M Wouters; Sander S Rensen; Joline W J Beulens; Marleen M J van Greevenbroek; Leen M 't Hart; Jan Willem M Greve; Carla J H van der Kallen; Nicolaas C Schaper; Casper G Schalkwijk; Coen D A Stehouwer; Martijn C G J Brouwers Journal: Liver Int Date: 2020-01-29 Impact factor: 5.828
Authors: Evelien J Vandercappellen; Annemarie Koster; Hans H C M Savelberg; Simone J P M Eussen; Pieter C Dagnelie; Nicolaas C Schaper; Miranda T Schram; Carla J H van der Kallen; Marleen M J van Greevenbroek; Anke Wesselius; Casper G Schalkwijk; Abraham A Kroon; Ronald M A Henry; Coen D A Stehouwer Journal: Diabetologia Date: 2022-02-04 Impact factor: 10.122